These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1402927)

  • 1. Sodium dependence of [3H]paroxetine binding and 5-[3H]hydroxytryptamine uptake in rat diencephalon.
    Mann CD; Hrdina PD
    J Neurochem; 1992 Nov; 59(5):1856-61. PubMed ID: 1402927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of serotonin transporter in goldfish retina by the binding of [3H]paroxetine and the uptake of [3H]serotonin: modulation by light.
    Lima L; Schmeer C
    J Neurochem; 1994 Feb; 62(2):528-35. PubMed ID: 8294915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ; Buckett WR
    Neuropharmacology; 1993 Aug; 32(8):737-43. PubMed ID: 8413837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes.
    Inserte J; Najib A; Pelliccioni P; Gil C; Aguilera J
    Biochem Pharmacol; 1999 Jan; 57(1):111-20. PubMed ID: 9920291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity and ontogeny of the central 5-HT transporter: effect of neonatal 5,7-dihydroxytryptamine lesions in the rat.
    Pranzatelli MR; Martens JM
    Brain Res Dev Brain Res; 1992 Dec; 70(2):191-5. PubMed ID: 1477953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine.
    Akunne HC; de Costa BR; Jacobson AE; Rice KC; Rothman RB
    Neurochem Res; 1992 Dec; 17(12):1275-83. PubMed ID: 1461373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes.
    Asano S; Matsuda T; Nakasu Y; Maeda S; Nogi H; Baba A
    Jpn J Pharmacol; 1997 Oct; 75(2):123-8. PubMed ID: 9414026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of essential sulfhydryl groups in drug interactions at the neuronal 5-HT transporter. Differences between amphetamines and 5-HT uptake inhibitors.
    Wolf WA; Kuhn DM
    J Biol Chem; 1992 Oct; 267(29):20820-5. PubMed ID: 1400397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autoradiographic study of dextromethorphan high-affinity binding sites in rat brain: sodium-dependency and colocalization with paroxetine.
    Meoni P; Tortella FC; Bowery NG
    Br J Pharmacol; 1997 Apr; 120(7):1255-62. PubMed ID: 9105700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter.
    Martin DC; Introna RP; Aronstam RS
    Neurosci Lett; 1990 Apr; 112(1):99-103. PubMed ID: 2143567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.
    Shearman LP; McReynolds AM; Zhou FC; Meyer JS
    Am J Physiol; 1998 Dec; 275(6):C1621-9. PubMed ID: 9843724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of [3H]paroxetine binding by various serotonin uptake inhibitors: structure-activity relationships.
    Marcusson JO; Norinder U; Högberg T; Ross SB
    Eur J Pharmacol; 1992 May; 215(2-3):191-8. PubMed ID: 1396986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.